“but when it does happen, it is gonna definitely accelerate our sales.”

In context

“st Larry. And you have accompanied this segment. It has significant impact. The challenge is not if these countries adopt it the question is when and how to forecast it. And it is difficult for me to, you know, with a business of this size to try and pinpoint the exact reimbursement. But I can tell you, we are very active and active discussions with very large markets. To expand or introduce reimbursement. If I look ahead at some of the key reimbursement expansions that are coming, obviously The US type 2 is a huge opportunity. it is going to unlock around 10 million Medicare beneficiaries. it is gonna accelerate commercial insurance coverage This could be a multibillion dollar opportunity, and it could happen in the fall. I just cannot forecast it exactly when exactly it is gonna happen, but when it does happen, it is gonna definitely accelerate our sales. And we are planning and positioning ourselves to be in the best possible position as it relates to Salesforce, distribution, etcetera. To be able to capitalize on that opportunity. The international basal coverage expansion I mean, right now, with all the with all the work that we have done, I would say you have got France, you have got Japan, you have got Canada that have broadly adopted this. You know, those are 3 markets that are in the top 10 international markets. There are another 7 markets here that are pretty significant movers, some larger than these that we are having discussions And given the clinical data, given the pressure from the societies and the patient populations, You know, those are gonna happen also. I just cannot call it to the exact quarter. So these reimbursement”